Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03073954
Other study ID # NL59883.068.17
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2017
Est. completion date July 1, 2019

Study information

Verified date March 2018
Source Maastricht University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

General cognitive impairment is highly prevalent in chronic obstructive pulmonary disease (COPD) patients. Domain-specific cognitive impairments include deficits in domains such as cognitive flexibility, verbal memory, working memory, planning, and psychomotor speed; which in general are associated with poor health behaviours, such as infrequent exercising and poor diet. Additional cognitive training may reverse these effects. Recent evidence suggests that working memory training is linked to self-control and, indirectly, to improved lifestyle behaviour including increased physical activity. The investigators hypothesise that enhancing cognitive performance through administering specific working memory training not only improves cognitive function but that it facilitates better adherence to a more active lifestyle and a healthier diet in COPD patients.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date July 1, 2019
Est. primary completion date July 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - primary diagnosis of COPD based on the Global Initiative for Chronic obstructive Lung Disease (GOLD) guidelines - Patients also need to provide written informed consent - Be motivated as evaluated by the self-determination questionnaire Exclusion Criteria: - Disease and or disability limiting the ability to undergo a neuropsychological testing battery and/or to follow a working memory training (e.g., blindness) - Neurological disorders (e.g., Alzheimer's Disease or cerebrovascular disease) - Insufficient mastery of the Dutch language - Individuals who during the study period are or will be participating in a PR programme

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Working memory training
The working memory intervention training programme consists of a domain-general cognitive working memory training programme. One training session will take 20 to 30 minutes, and participants will have to complete approximately 40 cognitive training sessions. The sham treatment is the same as the intervention training however it does not increase in difficulty. Participants are presented with the same task at the same level of difficulty over and over again. Thus a training effect is not expected.
Behavioral:
Standardised healthy lifestyle coaching
Participants will receive standardised healthy living coaching focusing on healthy diet and daily physical activity.

Locations

Country Name City State
Netherlands Maastricht University Maastricht Limburg

Sponsors (2)

Lead Sponsor Collaborator
Maastricht University Medical Center Eatwell

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of the cognitive training in COPD patients as measured through training compliance. The compliance as well as the acceptability of working memory training in the COPD patient population will be investigated 6 months
Primary Change in cognitive performance before and after working memory training as assessed through a cognitive test performance battery. Improvement in cognitive flexibility, planning, and working memory. 6 months
Secondary Self-control (impulsivity) This will be measured using the stop signal task. 6 months
Secondary Chronic stress levels as measured through hair levels of cortisol An objective measure of stress levels experienced over the last 3 months will be measured using cortisol extracted from a hair sample. 6 months
Secondary Stress levels as measured through the salivary cortisol awakening response An objective measure of stress will be measured using salivary cortisol awakening response 6 months
Secondary Stress perception as assessed through a perceived stress scale. A subjective measure of chronic stress will be measured using the perceived stress scale score. 6 months
Secondary Acute stress as assessed through the socially evaluated cold pressor test Acute stress will be measured using the socially evaluated cold pressor test, heart rate is also monitored. 6 months
Secondary Daily physical activity level Physical activity data will be collected by an accelerometer using step counts. 6 months
Secondary Mental health, depressive symptoms assessed via the BDI-II Mental health with respect to depression will be evaluated using the Beck Depression Inventory-second edition (BDI-II) 6 months
Secondary Mental health, anxiety symptoms assessed via the GAD-7 Mental health with respect to anxiety will be evaluated using the Generalised Anxiety Disorder 7 (GAD-7) 6 months
Secondary Physical performance assessed through the 6 minute walk test Changes in physical performance will be assessed using the 6-minute walking test (6MWT).Two six-minute walk tests (6MWT) will be performed according to ERS/ATS guidelines to measure functional exercise capacity. The best 6MWT will be expressed in percentage of predicted values. 6 months
Secondary Self-determination questionnaire Motivation will be prior to the enrolment of participants in this study in order to include patients who are motivated to initiate and continue our working memory training. The self-made questionnaire evaluates patient's reasons for participating in the study in order to assess their intrinsic motivation. 6 months
Secondary Short Performance Battery The SPPB consists of three types of physical manoeuvres: the balance tests, the gait speed test, and the chair stand test. The results of the different tests result in a score which will be used for analysis. 6 months
Secondary Changes in dietary intake over the intervention period Changes in dietary intake over the intervention period will be assessed using a food frequency questionnaire. 6 months
Secondary Medication adherence Medication adherence will be measured using a sem 6 months
Secondary Regulation of Eating Behavior Scale (REBS) Changes in eating behavior motivation will be investigated using the REBS. 6 months
Secondary Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2) Regulation Changes in exercise motivation will be investigated using the BREQ-2 6 months
Secondary COPD Assessment test (CAT) Impact of the intervention on quality of life will be done using the brief CAT questionnaire. 6 months
Secondary Anthropometry Alterations in Anthropometical measures will be evaluated using waist circumference, biometric impedance, and body weight (BMI). 6 months
Secondary Manipulation Check Participants will be asked to recall key health messages from their personalized healthy lifestyle advice sessions. Responses will be scored as follows: 0 points - field blank or no recall of the message content; 1 point - key points not directly related to the message themes; 2 points - key points directly related to the message themes. 6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06000696 - Healthy at Home Pilot
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Completed NCT04105075 - COPD in Obese Patients
Recruiting NCT05825261 - Exploring Novel Biomarkers for Emphysema Detection
Active, not recruiting NCT04075331 - Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial Phase 2/Phase 3
Terminated NCT03640260 - Respiratory Regulation With Biofeedback in COPD N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
Withdrawn NCT04210050 - Sleep Ventilation for Patients With Advanced Hypercapnic COPD N/A
Terminated NCT03284203 - Feasibility of At-Home Handheld Spirometry N/A
Recruiting NCT06110403 - Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness Phase 1/Phase 2
Active, not recruiting NCT06040424 - Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Recruiting NCT04868357 - Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program N/A
Completed NCT01892566 - Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV N/A
Completed NCT04119856 - Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD N/A
Completed NCT04485741 - Strados System at Center of Excellence
Completed NCT03626519 - Effects of Menthol on Dyspnoea in COPD Patients N/A
Recruiting NCT04860375 - Multidisciplinary Management of Severe COPD N/A